李靈軍

美國美國威斯康星大學麥迪遜分校（教授）

Dr. Lingjun Li is a Vilas Distinguished Achievement Professor and the Charles Melbourne Johnson Distinguished Chair Professor of Pharmaceutical Sciences and Chemistry at the University of Wisconsin-Madison (UW-Madison).? Dr. Li received her Ph.D. degree in Analytical Chemistry/Biomolecular Chemistry from the University of Illinois at Urbana-Champaign in 2000. She then did joint postdoctoral research at the Pacific Northwest National Laboratory and Brandeis University before joining the faculty at UW-Madison in December 2002. Dr. Li’s research interests include the development of novel mass spectrometry (MS)-based tools such as new isotopic and isobaric labeling strategies that enable hyperplexing for quantitative proteomics, peptidomics, metabolomics, and glycomics, and their applications in neuroscience and cancer research. Professor Li has established a highly productive research program and published more than 400 peer-reviewed research journal papers (with H-index of 64, and more than 16,149 citations) and has given more than 300 invited talks. Dr. Li has been recognized with numerous awards, including American Society for Mass Spectrometry (ASMS) Research Award, NSF CAREER Award, NSF Special Creativity Award, Sloan Fellowship, PittCon Achievement Award, and ASMS Biemann Medal, and was named one of the Top 50 most influential women in the analytical sciences in 2016 and was recently featured in the 2019 and 2021 Top 100 Power List by the Analytical Scientist (on a global scale). Dr. Li is currently serving as an Associate Editor for the Journal of the American Society for Mass Spectrometry (JASMS) and sitting on the Advisory Board for Analytical and Bioanalytical Chemistry and Mass Spectrometry Reviews. Dr. Li served on the Board of Directors for the US Human Proteome Organization (US HUPO) 2015-2018. Dr. Li was also the President for the Chinese American Society for Mass Spectrometry (CASMS has more than 1000 members in the US) for 2015-2017, and is currently the Chair for the CASMS Board of Directors。